• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人A3腺苷受体拮抗剂的定量构效关系研究:2-芳基-1,2,4-三唑并[4,3-α]喹喔啉衍生物

Quantitative structure-activity relationship study of human A3 adenosine receptor antagonists: derivatives of 2-aryl-1,2,4-triazolo [4,3-alpha]quinoxaline.

作者信息

Sharma B K, Singh P

机构信息

Department of Chemistry, S. K. Government College, Sikar 332 001, India.

出版信息

J Enzyme Inhib Med Chem. 2007 Apr;22(2):165-9. doi: 10.1080/14756360601051290.

DOI:10.1080/14756360601051290
PMID:17518342
Abstract

A quantitative structure-activity relationship (QSAR) study was conducted on the antagonistic activities of derivatives of 2-aryl-1,2,4-triazolo[4,3-alpha]quinoxaline at the human A3 adenosine receptor. As per the structural framework, the title analogues were subdivided into two congeneric series, namely the 1,4-dione and the 4-amino-1-one series. A majority of substituents occurred at the R- and a limited number at the X-positions in both of these series. In the case of the 1,4-dione series, the derived significant QSAR equation revealed that those substituents exhibiting a larger field effect at R renders the molecule to more efficiently bind at the receptor site. The study also extrapolated the requirement of electron-donor substituents at the X-position which, at present, is regarded as insensitive to any interaction due to limited substitution. However, the X-position may be explored in a further synthetic study. From the derived correlation equation for the 4-amino-1-one series, it appeared that a strong electron-withdrawing substituent at R will enhance the pK(i) value of a compound while a strong electron-donor at this position will have a detrimental effect on it. Based on correlation equations, derived using different electronic parameters, it may be interpreted that the two series of compounds attain different orientation inside the recognition site of the receptor.

摘要

对2-芳基-1,2,4-三唑并[4,3-α]喹喔啉衍生物在人A3腺苷受体上的拮抗活性进行了定量构效关系(QSAR)研究。根据结构框架,标题类似物被细分为两个同系物系列,即1,4-二酮系列和4-氨基-1-酮系列。在这两个系列中,大多数取代基出现在R位,少数出现在X位。对于1,4-二酮系列,推导得到的显著QSAR方程表明,在R位表现出较大场效应的取代基使分子更有效地结合在受体位点。该研究还推断了X位对供电子取代基的需求,目前由于取代有限,该位置被认为对任何相互作用不敏感。然而,在进一步的合成研究中可以探索X位。从4-氨基-1-酮系列推导得到的相关方程来看,R位上强吸电子取代基会提高化合物的pK(i)值,而该位置上的强供电子取代基则会对其产生不利影响。基于使用不同电子参数推导得到的相关方程,可以解释这两个系列的化合物在受体识别位点内具有不同的取向。

相似文献

1
Quantitative structure-activity relationship study of human A3 adenosine receptor antagonists: derivatives of 2-aryl-1,2,4-triazolo [4,3-alpha]quinoxaline.人A3腺苷受体拮抗剂的定量构效关系研究:2-芳基-1,2,4-三唑并[4,3-α]喹喔啉衍生物
J Enzyme Inhib Med Chem. 2007 Apr;22(2):165-9. doi: 10.1080/14756360601051290.
2
1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.1,2,4-三唑并[1,5-a]喹喔啉衍生物:作为腺苷受体拮抗剂的合成及生物学评价
Farmaco. 2004 Feb;59(2):71-81. doi: 10.1016/j.farmac.2003.09.005.
3
1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.1,2,4-三唑并[1,5-a]喹喔啉作为设计选择性人A3腺苷受体拮抗剂的通用工具:2-(杂)芳基和2-羧基取代衍生物的合成、生物学评价及分子模拟研究
J Med Chem. 2005 Dec 15;48(25):7932-45. doi: 10.1021/jm0504149.
4
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.1,2,4-三唑并[4,3-a]喹喔啉-1-酮部分作为开发新型强效和选择性人A3腺苷受体拮抗剂的有吸引力的骨架:合成、药理学及配体-受体模型研究
J Med Chem. 2004 Jul 1;47(14):3580-90. doi: 10.1021/jm031136l.
5
2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.2-芳基-8-氯-1,2,4-三唑并[1,5-a]喹喔啉-4-胺作为高效的A1和A3腺苷受体拮抗剂。
Bioorg Med Chem. 2005 Feb 1;13(3):705-15. doi: 10.1016/j.bmc.2004.10.050.
6
QSAR of adenosine A3 receptor antagonist 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives using chemometric tools.
Bioorg Med Chem Lett. 2005 Aug 15;15(16):3737-43. doi: 10.1016/j.bmcl.2005.05.051.
7
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists.阐明新型 2-芳基-吡唑并三唑嘧啶类化合物作为有效的人 A3 腺苷受体拮抗剂的药效团。
Bioorg Med Chem Lett. 2011 May 15;21(10):2898-905. doi: 10.1016/j.bmcl.2011.03.073. Epub 2011 Mar 26.
8
QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A(3) receptor subtype.QSAR 分析腺苷受体拮抗剂:探索吡唑并[4,3-e]-1,2,4-三唑并[1,5-c]嘧啶衍生物与人源腺苷 A(3)受体亚型结合的理化要求。
Bioorg Med Chem Lett. 2011 Jan 15;21(2):818-23. doi: 10.1016/j.bmcl.2010.11.094. Epub 2010 Nov 24.
9
1,2,4-triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A₃ receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies.1,2,4-三唑并[1,5-a]喹喔啉衍生物及其简化类似物作为腺苷A₃受体拮抗剂。合成、构效关系及分子模拟研究。
Bioorg Med Chem. 2015 Jan 1;23(1):9-21. doi: 10.1016/j.bmc.2014.11.033. Epub 2014 Nov 27.
10
QSAR of adenosine receptor antagonists. Part 3: Exploring physicochemical requirements for selective binding of 1,2,4-triazolo[5,1-i]purine derivatives with human adenosine A3 receptor subtype.腺苷受体拮抗剂的定量构效关系。第3部分:探索1,2,4-三唑并[5,1-i]嘌呤衍生物与人腺苷A3受体亚型选择性结合的物理化学要求。
Bioorg Med Chem Lett. 2004 Jul 16;14(14):3705-9. doi: 10.1016/j.bmcl.2004.05.007.